Navigation Links
Study to explore ethical challenges health professionals face while caring for children with LTNMDs
Date:1/7/2009

(Baltimore) The Greenwall Foundation recently awarded two core faculty members of the Johns Hopkins Berman Institute of Bioethics a grant that will allow Drs. Gail Geller and Cynda Hylton Rushton to explore the ethical challenges health professionals face while caring for children and families affected by life-threatening neuromuscular diseases (LTNMD).

The concept for this latest LTNMD study grew out of the work of the international HeartSongs Project funded by the Stavros Niarchos Foundation. The goal of the HeartSongs Project is to develop a worldwide network of professionals from a range of disciplines, parents and affected children who share a common vision of comprehensive care for children with LTNMD. In addition to the United States, countries involved in the HeartSongs project include the United Kingdom, Canada, Australia, France, Denmark and Greece. The Project aims to integrate the principles of pediatric palliative care (PPC) into the care of individuals living with LTNMDs. PPC can be described as a holistic, interdisciplinary model of care that incorporates emotional, spiritual, developmental, and physical dimensions. The HeartSongs' International Consortium will develop recommendations regarding promising practices in comprehensive and integrated care. The two-year project, co-directed by Geller and Rushton, opened with a summit in England this past April and will culminate in a second summit to be held in Greece in March 2009. Hopes for a HeartSongs II call for expanding the project to include more European countries as well as countries in South America, Africa, Asia and the Middle East.

The HeartSongs Project is named in honor of the young American poet Mattie J.T. Stepanek who lived with a rare form of muscular dystrophy. Mattie's messages of love, hope and peace have stirred the hearts and souls of millions worldwide. The author of 7 books, Mattie shared hope through his 'Heartsongs' poetry, and collaborated with For
'/>"/>

Contact: Ralph Loglisci
RalphL@jhu.edu
410-294-9071
Johns Hopkins Berman Institute of Bioethics
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...hazards , , FRIDAY, July 3 (HealthDay Ne...st 10,000 injuries every year in the United States... and others safe while enjoying the key summer hol... Corporation, which runs several Georgia-based med...safety: , Obey all local laws regarding firework...
(Date:7/3/2009)...es and three individuals have been recognized for ...al competition designed to reward workplace health...hange.org community released its 2009 Saxcies glob...afetyxchange.org/saxcies-video . The winners and f...heir lives to keeping others safe - are detailed h...
(Date:7/3/2009)...th care reform details emerge, more entrepreneurs ...ups and business insurance premiums. Now, they are...such as the Small Business Health Insurance Networ...nneapolis, Minn. (PRWEB) July 3, 2009 -- The healt...se, which has entrepreneurs worried about how this...
(Date:7/2/2009)...swire/ -- Pro-life forces won an important battle ...old a state law regulating that abortion centers m...g RU-486 (also known as the "abortion pill") in or... , , The ruling came in Rogers v. Planned Par...004 law requiring that those administering RU-486 ...
Breaking Medicine News(10 mins):Health News:Put Safety First on the 4th 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2
... critically injured in a car accident, skull separ...ry. Doctors call her recovery a miracle. A car c...arated from her spine, although her skin, spinal c...intact. The rare condition is known clinically as ...
... delivered his famous Gettysburg Address, he was i... new study by two University of Texas researchers...hat Lincoln was ill, following his Gettysburg spee...suffering from a very mild form of smallpox, one t...
...ional Cancer Institute and Fred Hutchinson Cancer ...nt predominately found in tomatoes , does not effe...earchers noted an association between beta-caroten...ed to lycopene, and an increased risk for aggressi...
...President set a target of ten years for developing... . "We have learned in that period of time how fo...ayne Koff, senior vice president for research and ...ational AIDS Vaccine Initiative (IAVI). Global sp...
Other Medicine News:Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:Study Finds That Lincoln Suffered from Smallpox During Gettysburg Speech 2Health News:Tomatoes are Not So Effective in Preventing Prostate Cancer 2Health News:AIDS Vaccine Still a Long Way Off 2
(Date:6/30/2009)... -- Cephalon, Inc. (Nasdaq: CEPH ) today announc...pplication (sNDA) to the U.S. Food and Drug Admini...armodafinil) Tablets [C-IV] for the indication of ...eepiness associated with jet lag disorder resultin...cute condition that occurs when a person,s interna...
(Date:6/29/2009)...n in Outpatient Setting During First Year of Life;... , GAITHERSBURG, Md., June 29 Me...iatric research with today,s announcement of the f...ssess the burden of respiratory syncytial virus (R...al age (GA) in outpatient settings during their fi...
(Date:6/29/2009)...cs Based On Naturally Resected tRNA Synthetases ,...Pharma, a subsidiary of aTyr Pharma in Hong Kong, ...lication on proprietary, naturally occurring, rese...tases are universal and essential components of pr...human synthetases have naturally occurring resecte...
(Date:6/28/2009)...9 Data presented,today, in Budape...vel,once-daily anti-epileptic Zebinix(R)* (eslic... sustained decrease in seizure frequency over the ...xtension of a pivotal Eslicarbazepine Acetate,pha...ongress for Epilepsy in,Budapest, Hungary. Patien...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 1New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 2TriCipher Joins SAFE BioPharma Association Vendor Partner Program 1406 1TriCipher Joins SAFE BioPharma Association Vendor Partner Program 1406 2From terror to joy 3A faced with death our minds turn to happier thoughts 4251 1From terror to joy 3A faced with death our minds turn to happier thoughts 4251 2Are some men predisposed to pedophilia 3F 907 1
... Affiliated Physicians Participate in ASCO,Proceed...ding cancer,researcher affiliated with the US Onco...ndomized, multicenter phase III trial,that compare...o,regimens of adjuvant therapy for patients with h...iven in an oral presentation by Dr.,David Loesch o...
...s.--(BUSINESS WIRE)--Jun 5, 2007 - Synta,Pharmaceu...ompany,focused on discovering, developing, and com...medical conditions, today announced,it will hold a...ss,these results, which will be presented at the a...Oncology (ASCO) in Chicago, Illinois,this morning....
Other Medicine Technology:New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5
The Ultramatic Rx Master is designed and constructed to provide years of reliable service and give the professional distinctive features that measurably improve procedures. It embodies the characteri
Maddox Rod, long handle
Snellen 20' Eye Test Chart.
..., with large high resolution LCD touch screen and ... digital pachymeter which provides easy-to-use tou...quency, low noise probe and fast precise algorithm... of the probe along the visual axis. The PacScan 3...
Medicine Products: